NCT00346996View on ClinicalTrials.gov

Insulin Analogues and Severe Hypoglycaemia

PHASE4CompletedINTERVENTIONAL

Enrollment

179

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

November 30, 2011

Study Completion Date

August 31, 2012

Conditions

Type 1 Diabetes

Interventions

DRUG

insulin levemir / aspart

for subcutaneous injection

DRUG

human insulin /insulin isophane

for subcutaneous injection

Trial Locations (1)

DK-2820

Steno Diabetes Center, Gentofte Municipality

Sponsors

Collaborators (1)

Novo Nordisk A/S

All Listed Sponsors

collaborator

Novo Nordisk A/S

INDUSTRY

lead

Lise Tarnow

OTHER